CSPC Pharmaceutical Group Limited
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CSPCY research report →
Companywww.cspc.com.hk
CSPC Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical products in the People's Republic of China, other Asian regions, the Americas, Europe, and internationally. The company operates through Finished Drugs, Bulk Products, and Functional Food and Others segments. It provides NBP soft capsules and injections for acute ischemic stroke; Oulaining capsules and injections to treat mild to moderate memory and mental impairment; Enxi to treat adult idiopathic Parkinson's disease; Duomeisu for lymphoma, multiple myeloma, ovarian and breast cancers, and other malignant tumors; Jinyouli to prevent leucopenia and infection induced by chemotherapy; and Keaili for breast cancer.
- CEO
- Lei Cai
- IPO
- 2021
- Employees
- 21,400
- HQ
- Shijiazhuang, CN
Price Chart
Valuation
- Market Cap
- $10.46B
- P/E
- 18.25
- P/S
- 2.73
- P/B
- 2.23
- EV/EBITDA
- 10.90
- Div Yield
- 3.25%
Profitability
- Gross Margin
- 65.60%
- Op Margin
- 15.45%
- Net Margin
- 15.12%
- ROE
- 12.19%
- ROIC
- 9.03%
Growth & Income
- Revenue
- $25.29B · -18.07%
- Net Income
- $3.78B · -18.03%
- EPS
- $1.32 · -15.38%
- Op Income
- $3.86B
- FCF YoY
- 91.36%
Performance & Tape
- 52W High
- $5.83
- 52W Low
- $3.27
- 50D MA
- $4.45
- 200D MA
- $4.64
- Beta
- 0.80
- Avg Volume
- 2.62K
Get TickerSpark's AI analysis on CSPCY
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our CSPCY Coverage
We haven't published any research on CSPCY yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate CSPCY Report →